Functional autoantibodies, a new paradigm in autoimmunity?

Autoimmunity Reviews

Volumn 7, Issue 1, 2007, Pages 42-45

  Gleicher, Norbert ^a,b   Barad, David ^a,b   Weghofer, Andrea ^c  

^a CENTER FOR HUMAN REPRODUCTION   (United States)

^b Foundation for Reproductive Medicine   (United States)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

Autoantibodies; Autoimmune diseases; Autoimmunity; Polycystic ovarian syndrome (PCOS); Premature ovarian aging (POA); Scleroderma systemic sclerosis; Thyroid disease

Indexed keywords

AUTOANTIBODY; PHOSPHOLIPID ANTIBODY; PLATELET DERIVED GROWTH FACTOR;

ADRENAL DISEASE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CLINICAL STUDY; HUMAN; OVARY POLYCYSTIC DISEASE; PATHOPHYSIOLOGY; PREMATURE OVARIAN FAILURE; REVIEW; SCLERODERMA; THYROID FUNCTION;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; AUTOIMMUNITY; FEMALE; HUMANS; IMMUNOGLOBULINS, THYROID-STIMULATING; OVARIAN FAILURE, PREMATURE; OVARY; POLYCYSTIC OVARY SYNDROME; SCLERODERMA, SYSTEMIC; THYROIDITIS, AUTOIMMUNE;

EID: 35448996922     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2007.06.001     Document Type: Review

References (34)

1. Davidson A., and Diamond B. Autoimmune diseases. N Engl J Med 345 (2001) 340-350
2. National institutes of health autoimmune disease coordination committee report; 2002 (2002), The Institute, Bethesda, M.D.
3. Tomer Y., and Shoenfeld Y. The significance of natural autoantibodies. Immunol Invest 17 (1988) 389-324
4. George J., Gilburd B., and Shoenfeld Y. The emerging concept of pathogenic natural autoantibodies. Hum Antibodies 8 (1997) 70-75
5. Lacroix-Desmazes S., Kaveri S.V., Mouthon L., Ayouba A., Malanchėre E., Coutinho A., and Kazatchkine M.D. Self-reactive antibodies (natural autoantibodies) in healthy individuals. J Immunol Methods 216 (1998) 117-137
6. Baumgarth N., Tung J.W., and Herzenberg L.A. Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion. Springer Semin immunopathol 26 (2005) 347-362
7. Shoenfeld Y., and Toubi E. Protective autoantibodies. Rheum. Arthritis 52 (2005) 2599-2606
8. Shoenfeld Y., and Poletaev A.B. Natural autoimmunity in physiology and pathology. 1st Moscow international conference, Moscow, Russia, September 15-17, 2005. Autoimmune Rev vol. 5 (2006) 357-363
9. Fleming S.D., and Tsokos G.C. Complement, natural antibodies, autoantibodies and tissue injury. Autoimmune Rev 5 (2006) 89-92
10. Gabibov A.G., Ponomarenko N.A., Tretykak E.B., Paltsev M.A., and Suchov S.V. Catalytic autoantibodies in clinical autoimmunity and modern medicine. Autoimmune Rev 5 (2006) 324-330
11. Bayry J., Lacroix-Desmazes S., Pashov A., Stahl D., Hoebeke J., Kazatchkine M.D., and Kaveri S.V. Autoantibodies to factor VII with catalytic activity. Autoimmune Rev 2 (2003) 30-35
12. Gleicher N., Harlow Z., and Zilberstein M. Regulatory effect of antiphospholipid antibodies on signal transduction. Am J Obstet Gynecol 167 (1992) 637-642
13. Ando T., and Davies T.F. Monoclonal antibodies to the thyrotropin receptor. Clin Dev Immunol 12 (2005) 137-143
14. Dragan L.R., Seiff S.R., and Lee D.C. Longitudinal correlation of thyroid-stimulating immunoglobulin with clinical activity of disease in thyroid-associated orbitopathy. Ophthal Plast Reconstr Surg 22 (2006) 13-19
15. Goh S.Y., Ho S.C., Seah L.L., Fong K.S., and Khoo D.H. Thyroid autoantibody profiles in ophthalmic dominant and thyroid dominant Graves' disease differ and suggest ophthalmopathy is a multiantigenic disease. Clin Endocrinol 60 (2004) 600-607
16. Eckstein A.K., Plicht M., Lax H., Hirche H., Quadbeck B., Mann K., Steuhl K.P., Esser J., and Morgenthaler N.G. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies. Clin Endocrinol (Oxf) 61 (2004) 612-618
17. Poletaev A., and Osipenko L. General network of natural autoantibodies as immunological homunculus (Immunculus). Autoimmune Rev 2 (2003) 264-271
18. Baroni S.S., Santillo M., Bevilacqua F., Luchetti M., Spadoni T., Mancini M., Fraticelli P., Sambo P., Funaro A., Kazlauskas A., Avvedimento E.V., and Gabrielli A. Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N Engl J Med 354 (2006) 2667-2676
19. Tan F.K. Autoantibodies against PDGF receptor in scleroderma. N Engl J Med 354 (2006) 2709-2711
20. Hoek A., Schoemaker J., and Drexhagen H.A. Premature ovarian failure and ovarian autoimmunity. Endocr Rev 18 (1997) 107-134
21. Franks S., Mason H., and Willis D. Follicular dynamics in the polycystic ovary syndrome. Mol Cell Endocrinol 163 (2000) 49-52
22. Ehrman D.A. Polycystic ovary syndrome. N Engl J Med 352 (2005) 1223-1236
23. Nikolaou D., and Templeton A. Early ovarian ageing. Eur J Obstet Gynecol Reprod Biol 113 (2004) 126-133
24. Gleicher N. Ovarian aging: is there a "norm"?. Cont Ob/Gyn 50 (2005) 65-75
25. Nikolaou D., and Gilling-Smith C. Early ovarian ageing: are women with polycyctic ovaries protected?. Hum Reprod 19 (2004) 2175-2179
26. Gleicher N. An evolutionary concept of polycystic ovarian disease: does evolution favour reproductive success over survival?. Reprod Biomed Online 5 (2006) 587-589
27. Siegel S.F., Finegold D.N., Lanes R., and Lee P.A. ACTH stimulation tests and plasma dehydroepiandrosterone sulfate levels in women with hirsutism. N Engl J Med 323 (1990) 849-854
28. Gleicher N., Weghofer A., and Barad D. Adrenal function in women with premature aging ovaries. Fertil Steril 86 Supl 2 (2006) S401
29. Gleicher N, Weghofer A, Wilson R, Barad D. Premature ovarian aging (POA), characterized by premature FSH elevations and adrenal abnormalities: the opposing extreme to polycystic ovaries (PCO) in ovarian function? Submitted for publication.
30. Weghofer A., Munne S., Chen S., Barad D., and Gleicher N. Lack of association between increased aneuploidy and polycystic ovarian syndrome. Fertil Steril (April 12 2007) [Electronic publication ahead of print]
31. Weghofer A., Barad D., Li J., and Gleicher N. Aneuploidy rates in embryos from women with prematurely declining ovarian function: a pilot study. Fertil Steril 88 (2007) 90-94
32. Van Gelderen C.J., and Gomes dos Santos M.I. Polycystic ovarian syndrome. Evidence for an autoimmune mechanism in some cases. J Reprod Med 38 (1993) 381-386
33. Betterle C., dal Pra C., Mantero F., and Zanchetta R. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens and their applicability in diagnosis and disease prediction. Endocr Rev 23 (2002) 327-364 [Erratum. Endocr Rev 2002;23:579]
34. Dal Pra C., Chen S., Furmaniak J., Smith B.R., Pedini B., Moscon A., Zanchetta R., and Betterle C. Autoantibodies to steroidogenic enzymes in patients with premature ovarian failure with and without Addison's disease. Eur J Endocrinol 148 (2003) 565-570